ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,306.04
      0.02%
      US Tech 100
      18,387.60
      0.38%
      Dow Jones
      38,852.86
      -0.55%
      Brent Oil
      84.145
      -0.21%
      Bitcoin
      68,694.63
      0.59%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Scinai Immunotherapeutics Ltd (SCNI)

      7. Scinai Immunotherapeutics Ltd (SCNI) News

      SCNI Scinai Immunotherapeutics Ltd

      3.75
      -0.39 (-9.42%)
      May 28 2024 - Closed
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Scinai Immunotherapeutics Ltd SCNI NASDAQ Depository Receipt
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      -0.39 -9.42% 3.75 20:00:00
      Open Price Low Price High Price Close Price Prev Close
      3.97 3.5691 3.97 3.75 4.14
      more quote information »

      Recent News

      Date Time Source Heading
      5/28/202414:14EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      5/24/202416:01PRNUSScinai Immunotherapeutics Announces Receipt of a Nasdaq..
      5/16/202413:49EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
      5/15/202417:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      5/15/202416:01PRNUSScinai Publishes FY 2023 Financial Statements, Files Annual..
      5/07/202410:24EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      5/06/202409:21PRNUSScinai Immunotherapeutics Announces Receipt of Nasdaq..
      4/10/202407:00PRNUSScinai to showcase its novel biological local therapeutic..
      4/08/202417:15APSBiotech Rips Following Five-Year Master Service Agreement..
      4/08/202407:00PRNUSScinai Immunotherapeutics' CDMO Unit Selected by Ayana..
      3/12/202408:00PRNUSScinai leadership to attend BIO-Europe Spring 2024
      2/29/202408:45PRNUSScinai to showcase its cGMP biologics CDMO and innovative..
      2/13/202407:00PRNUSScinai Welcomes Liat Halpert as Head of Business Development..
      1/30/202416:19EDGAR2Form F-3 - Registration statement by foreign private issuers
      1/25/202410:26PRNUSScinai Immunotherapeutics Congratulates its Co-Lead..
      1/24/202414:33EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      1/18/202411:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      1/12/202407:32EDGAR2Form D - Notice of Exempt Offering of Securities
      1/09/202408:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      1/04/202416:37EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      1/04/202416:01PRNUSScinai Immunotherapeutics Announces Closing of Exercise of..
      1/04/202406:15PRNUSScinai Immunotherapeutics CEO Issues Letter to Shareholders
      1/02/202409:58EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
      1/02/202409:57EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
      1/02/202409:26EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      1/02/202409:24EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      1/02/202408:24EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
      12/29/202309:21PRNUSScinai Immunotherapeutics Announces Exercise of Outstanding..
      12/27/202307:15PRNUSScinai (NASDAQ: SCNI) to Host Analyst and Investor Webinar..
      12/22/202309:11EDGAR2Form F-1/A - Registration statement for certain foreign..
      12/14/202306:21EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      12/12/202307:26PRNUSScinai Announces Promising Results in a Psoriatic Human Skin..
      12/11/202308:11PRNUSStudy published in Antiviral Research supports promise of..
      11/29/202309:25PRNUSEuropean Investment Bank (EIB) extends maturity of its..
      11/20/202310:49EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      11/20/202307:30PRNUSScinai Immunotherapeutics Regains Compliance with Nasdaq's..
      11/13/202308:25EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      11/07/202306:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      11/06/202307:30GLOBEScinai Immunotherapeutics Announces Award of Non-Dilutive..
      11/03/202316:30GLOBEScinai Immunotherapeutics Provides Update Regarding Nasdaq..
      11/03/202308:49EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      11/02/202313:21EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      10/31/202309:00GLOBEEuropean Investment Bank (EIB) considering extending..
      10/31/202308:23GLOBEScinai Reports Third Quarter 2023 Financial Results and..
      10/30/202316:59EDGAR2Form F-1 - Registration statement for certain foreign..
      10/30/202307:00GLOBEScinai Immunotherapeutics to Attend BIO-Europe Munich 2023
      10/04/202307:30GLOBEScinai Immunotherapeutics to Showcase its end-to-end cGMP..
      9/22/202316:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      9/20/202306:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      9/19/202316:05GLOBEScinai Immunotherapeutics Announces Closing of $1.33 Million..

      Your Recent History

      NASDAQ
      SCNI
      Scinai Immunotherapeutics
      UNSW
      NFYETH
      Non-Fungible Yearn
      BITMOT
      821761
      Pfizer Tf 1% Mz27 Call Eur
      BIT
      IRE
      Iren
      BIT
      I04635
      Banca IMI
      BIT
      UB593N
      Unicredit Bank
      Delayed Upgrade Clock